Cardiovascular Disease Clinical Research

Reducing the burden of cardiovascular disease in patients

As a leading life-shortening disease, cardiovascular diseases are critical to prevent and treat immediately in patients around the world. The clinical trial process is complicated and full of unknowns, and even the best cardiovascular therapeutic might not make it to the patients that need it, not because it does not work but because the design, data collection, and analysis were not done right.

At Veristat, we have assembled an extraordinary team of scientific-minded experts who have mastered the complexities of running cardiovascular disease trials. We have supported more than 200 projects for cardiovascular treatments, diagnostics, and medical devices.

Improving Cardiovascular Disease Outcomes Through Expertise

The acute nature of most cardiology/vascular diseases makes them highly complex to treat. Our diverse trial experience, coupled with our knowledgeable and experienced teams, allows us to confidently handle the most complex trials and patient populations with the attention and focus needed to navigate the cardiology/vascular disease landscape.

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:

Development of regulatory strategy, expedited pathways, and regulatory agency interactions
Clinical program planning, inclusive of statistical planning and analysis
Agile patient recruitment strategies to support virtual trial and hybrid approaches
Rapid deployment of clinical trial databases
Virtual and remote clinical and medical site monitoring
Data analysis and migration into CDISC formats
Writing of clinical trial, safety, and regulatory documents
Preparation and defense of Marketing Applications – NDAs, BLAs, NDSs, MAAs, jNDAs, etc.

Background Banner Video

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Driving Successful Outcomes for Cardiovascular Trials
Abdominal Aortic Aneurysm (AAA)	Ehlers-Danlos Syndrome (EDS)	Ischemic Heart Disease
Acute Coronary Syndrome	Electrocardiogram (ECG)	Myocardial Infarction
Acute Hereditary Angioedema Attacks	Endocarditis	Pericarditis
Blood/Brain Barrier Crossing of Drug	Familial Chylomicronemia Syndrome (FCS)	Raynaud's Disease
Cardiac Fibrosis	Heart Failure	Stroke - Aneurysmal Subarachnoid Hemorrhage (aSAH)
Cardiac Imaging	Hereditary Transthyretin Amyloidosis (hATTR)	Treatment after Creation of Arteriovenous Access for Hemodialysis Use
Coronary Arterial Restenosis	Homozygous Familial Hypercholesterolemia (HoFH)	Vascular Access Graft
Coronary Artery Bypass Grafting (CABG)	Hyperlipoproteinemia(a) and Established Cardiovascular Disease (CVD)	Vascular Ehlers-Danlos Syndrome (EDS)
Coronary Artery Disease	Hypertension	Vascular Injury
Critical Limb Ischemia	Hypertriglyceridemia	Venous Leg Ulcers (VLU)

Learn More with These Resources

Webinar Presentation

Webinar: Virtual Trial Planning Lessons Learned

Get the webinar presentation to see lessons learned and recommendations for designing protocols that enable flexibility in your virtual trials' ...

open

Case Study

Writing Multiple Marketing Applications At The Same Time

A mid-size pharmaceutical company and its development partner, a small biotechnology company engaged Veristat to complete the medical writing for their product’s ...

download

Fact Sheet

Cardiovascular Experience Fact Sheet

With Cardiovascular Diseases being the leading cause of death worldwide, Veristat is committed to supporting cardiovascular clinical trials to make a difference in ...